HDCN Article Review/Hyperlink

SPORTIF III Investigators

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III)

Lancet (Nov) 362:1691-1698, 2003

The abstract of this paper is available from the Lancet. However, you must register at the Lancet site first as a non-subscriber (you can get there via the journals page of HDCN).

Once you have registered at the Lancet site, click here for the abstract.
         Related Folders:

Return to Home